---
figid: PMC6771012__genes-10-00709-g003
figtitle: Molecules and cellular pathways that contribute to thyroid cancer development
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6771012
filename: genes-10-00709-g003.jpg
figlink: /pmc/articles/PMC6771012/figure/genes-10-00709-f003/
number: F3
caption: Molecules and cellular pathways that contribute to thyroid cancer development.
  Alterations in ALK, RET or other RTKs up-regulate RAS thereby pathologically modulating
  the MAPK and PI3K pathways that favor thyroid cell survival, de-differentiation
  and improper gene transcription. Mutations in the WNT pathway (CTNNB1, AXIN) and
  in other molecules (TERT, PPARγ, HMT, SW1-SNF, TP53) promote oncogenic activity,
  reduce apoptosis and compromise DNA repair (MMR). IDH1 or EIF1AX mutations alter
  epigenetic mechanisms or cause a defective assembly of the 43S-complex, respectively.
  Additional mutations in specific genes (BRAF, PTEN) promote the transition from
  differentiated to undifferentiated thyroid cancer. * indicates genes directly involved
  in thyroid carcinogenesis
papertitle: 'Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.'
reftext: Elena Tirrò, et al. Genes (Basel). 2019 Sep;10(9):709.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9513658
figid_alias: PMC6771012__F3
figtype: Figure
redirect_from: /figures/PMC6771012__F3
ndex: e2e922b3-def3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6771012__genes-10-00709-g003.html
  '@type': Dataset
  description: Molecules and cellular pathways that contribute to thyroid cancer development.
    Alterations in ALK, RET or other RTKs up-regulate RAS thereby pathologically modulating
    the MAPK and PI3K pathways that favor thyroid cell survival, de-differentiation
    and improper gene transcription. Mutations in the WNT pathway (CTNNB1, AXIN) and
    in other molecules (TERT, PPARγ, HMT, SW1-SNF, TP53) promote oncogenic activity,
    reduce apoptosis and compromise DNA repair (MMR). IDH1 or EIF1AX mutations alter
    epigenetic mechanisms or cause a defective assembly of the 43S-complex, respectively.
    Additional mutations in specific genes (BRAF, PTEN) promote the transition from
    differentiated to undifferentiated thyroid cancer. * indicates genes directly
    involved in thyroid carcinogenesis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RET
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ALK
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ADAR
  - DVL1P1
  - KRAS
  - HRAS
  - NRAS
  - JAK2
  - AKT1
  - AKT2
  - AKT3
  - BRAF
  - APC
  - PROC
  - MTOR
  - GSK3B
  - AXIN1
  - AXIN2
  - CTNNB1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MDM2
  - TP53
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - TERT
  - MRC1
  - HNMT
  - ARID1A
  - ARID1B
  - SMARCA1
  - SMARCA2
  - SMARCA4
  - SMARCA5
  - SMARCB1
  - SMARCC1
  - SMARCC2
  - SMARCD1
  - SMARCD2
  - SMARCD3
  - SMARCE1
  - ACTL6A
  - ACTL6B
  - HLTF
  - EIF2B5
  - RTRAF
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIP
  - Cancer
  - Lung cancer
---
